Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study.

Main|Search|PHGKB




Last Posted: Aug 24, 2017

---

• Assessing the Fragile X Syndrome Newborn Screening Landscape.  
  Riley Catharine et al. Pediatrics 2017 Jun 139(Suppl 3) S207-S215
• Contribution of birth defects and genetic diseases to pediatric hospitalizations. A population-based study.  
  Yoon P W et al. Archives of pediatrics & adolescent medicine 1997 Nov 151(11) 1096-103
• Newborn screening for cystic fibrosis: a paradigm for public health genetics policy development. Proceedings of a 1997 workshop.  
  et al. MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports 1997 Dec 46(RR-16) 1-24
• Multilevel research and the challenges of implementing genomic medicine.  
  Khoury Muin J et al. Journal of the National Cancer Institute. Monographs 2012 May (44) 112-20
• Economic analysis of ALK testing and crizotinib therapy for advanced non-small-cell lung cancer.  
  Lu Shun et al. Pharmacogenomics 2016 Jun 17(9) 985-94
• Endogenous information, adverse selection, and prevention: Implications for genetic testing policy.  
  Peter Richard et al. Journal of health economics 2017 Jul
• Genome privacy: challenges, technical approaches to mitigate risk, and ethical considerations in the United States.  
  Wang Shuang et al. Annals of the New York Academy of Sciences 2017 Jan (1) 73-83
• Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea.  
  Lim Eun-A et al. PloS one 2016 11(8) e0160155
• Finding the Rare Pathogenic Variants in a Human Genome.  
  Evans James P et al. JAMA 2017 317(18) 1904-1905
• Cost-effectiveness of population based BRCA testing with varying Ashkenazi Jewish ancestry.  
  Manchanda Ranjit et al. American journal of obstetrics and gynecology 2017 Jul
• PCSK9 inhibitor access barriers-issues and recommendations: Improving the access process for patients, clinicians and payers.  
  Baum Seth J et al. Clinical cardiology 2017 Apr 40(4) 243-254
• The Role of Genetic Testing in Patients With Breast Cancer: A Review.  
  Valencia Olivia M et al. JAMA surgery 2017 Jun 152(6) 589-594
• Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.  
  Finney Rutten Lila J et al. Mayo Clinic proceedings 2017 May (5) 726-733
• Direct-to-Consumer Medical Testing in the Era of Value-Based Care.  
  Rockwell Kimberly Lovett et al. JAMA 2017 May
• Polygenic Risk Score Identifies Subgroup with Higher Burden of Atherosclerosis and Greater Relative Benefit from Statin Therapy in the Primary Prevention Setting.  
  Natarajan Pradeep et al. Circulation 2017 Feb
• Tissue-based next generation sequencing: application in a universal healthcare system.  
  Hynes Seán O et al. British journal of cancer 2017 Feb 116(5) 553-560

more